JK
Joshua Kennedy-Smith
OtherActiveManaging Director at RTW Investments, LP
32
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Joshua Kennedy-Smith.
Investment Thesis & Strategy
RTW Investments, LP invests in various stages of biotech and pharmaceutical companies. They seek to invest in companies with strong management teams and promising pipelines.
Investment Activity
Deals per year over the last 5 years
4
20161
20172
20182
20191
2020Portfolio Companies
Selected investments from their portfolio of 32 companies
C
C4 Therapeutics
Other · , 0
P
Pyxis Oncology
Other · , 0
B
Biomea Fusion
Biotech · Series B, 2020
V
Ventyx Biosciences
Biotech · Series B, 2019
A
Artiva Biotherapeutics
Biotech · Series B, 2019
A
Attune Pharmaceuticals
Biotech · Seed, 2018
V
Visus Therapeutics
Biotech · Series B, 2018
N
Nuance Biotech
Biotech · Seed, 2017
N
NiKang Therapeutics
Biotech · Series B, 2016
P
Prometheus Biosciences
Biotech · Series B, 2016
T
Tenaya Therapeutics
Biotech · Series B, 2016
S
Solid Biosciences
Biotech · Series B, 2016
Frequently Asked Questions
Joshua Kennedy-Smith focuses on Series B stage investments.